Altered somatic hypermutation patterns in COVID-19 patients classifies disease severity

Abstract

These features may be used to build and adapt therapeutic strategies to COVID-19, in particular to quantitatively assess potential diagnostic and therapeutic antibodies. These results constitute a proof of concept for future epidemiological challenges.